Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
Publication
, Journal Article
Sanli, Y; Zukotynski, K; Mittra, E; Chen, DL; Nadel, H; Niederkohr, RD; Subramaniam, RM
Published in: Clin Nucl Med
December 2018
There are recent advances, namely, a standardized method for reporting therapy response (Hopkins criteria), a multicenter prospective cohort study with excellent negative predictive value of F-FDG PET/CT for N0 clinical neck, a phase III multicenter randomized controlled study establishing the value of a negative posttherapy F-FDG PET/CT for patient management, a phase II randomized controlled study demonstrating radiation dose reduction strategies for human papilloma virus-related disease, and Food and Drug Administration approval of nivolumab for treatment of recurrent head and neck squamous cell carcinoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Nucl Med
DOI
EISSN
1536-0229
Publication Date
December 2018
Volume
43
Issue
12
Start / End Page
e439 / e452
Location
United States
Related Subject Headings
- Squamous Cell Carcinoma of Head and Neck
- Randomized Controlled Trials as Topic
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Multimodal Imaging
- Magnetic Resonance Imaging
- Humans
- Head and Neck Neoplasms
- Fluorodeoxyglucose F18
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanli, Y., Zukotynski, K., Mittra, E., Chen, D. L., Nadel, H., Niederkohr, R. D., & Subramaniam, R. M. (2018). Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer. Clin Nucl Med, 43(12), e439–e452. https://doi.org/10.1097/RLU.0000000000002247
Sanli, Yasemin, Katherine Zukotynski, Erik Mittra, Delphine L. Chen, Helen Nadel, Ryan D. Niederkohr, and Rathan M. Subramaniam. “Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.” Clin Nucl Med 43, no. 12 (December 2018): e439–52. https://doi.org/10.1097/RLU.0000000000002247.
Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, et al. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer. Clin Nucl Med. 2018 Dec;43(12):e439–52.
Sanli, Yasemin, et al. “Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.” Clin Nucl Med, vol. 43, no. 12, Dec. 2018, pp. e439–52. Pubmed, doi:10.1097/RLU.0000000000002247.
Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, Subramaniam RM. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer. Clin Nucl Med. 2018 Dec;43(12):e439–e452.
Published In
Clin Nucl Med
DOI
EISSN
1536-0229
Publication Date
December 2018
Volume
43
Issue
12
Start / End Page
e439 / e452
Location
United States
Related Subject Headings
- Squamous Cell Carcinoma of Head and Neck
- Randomized Controlled Trials as Topic
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Multimodal Imaging
- Magnetic Resonance Imaging
- Humans
- Head and Neck Neoplasms
- Fluorodeoxyglucose F18